Smoking and asthma

Journal of the American Board of Family Medicine

Volumn 24, Issue 3, 2011, Pages 313-322

  Stapleton, Megan ^a   Howard Thompson, Amanda ^b   George, Christa ^b   Hoover, Robert M ^b   Self, Timothy H ^b  

^a TEXAS TECH UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Asthma; Inhaled corticosteroid resistance; Secondhand smoke; Smoking

Indexed keywords

BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR; BUDESONIDE; CORTICOSTEROID; CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PROTEIN X; FLUTICASONE PROPIONATE; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; HISTAMINE; HISTONE DEACETYLASE; HYDROFLUOROALKANE BECLOMETHASONE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 8; METHACHOLINE; PREDNISOLONE; SALBUTAMOL; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABSENTEEISM; ASTHMA; BRONCHIOLITIS; BRONCHUS HYPERREACTIVITY; CAREGIVER; CHILD; CHILDHOOD DISEASE; CIGARETTE SMOKING; COUNSELING; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG ACTIVITY; DRUG BINDING; DRUG EFFECT; DRUG MEGADOSE; DRUG RESISTANCE; ENZYME ACTIVITY; EOSINOPHIL; EOSINOPHIL COUNT; EXPOSURE; FORCED EXPIRATORY VOLUME; GROUPS BY AGE; HEALTH SURVEY; HUMAN; INTUBATION; LOW DRUG DOSE; LUNG FUNCTION; LYMPHOCYTE; MATERNAL SMOKING; MEMBRANE PERMEABILITY; MILD PERSISTENT ASTHMA; MODERATE PERSISTENT ASTHMA; MORBIDITY; NOSE ALLERGY; OUTCOME ASSESSMENT; PASSIVE SMOKING; PEAK EXPIRATORY FLOW; PREVALENCE; PROGNOSIS; PSYCHOSOCIAL DISORDER; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEPTOR DOWN REGULATION; RESPIRATION CONTROL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT MUCOSA; REVIEW; SEVERE PERSISTENT ASTHMA; SIGNAL TRANSDUCTION; SINUSITIS; SPUTUM; TOBACCO DEPENDENCE; TREATMENT RESPONSE;

ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; CONFIDENCE INTERVALS; DRUG RESISTANCE; FEMALE; HUMANS; ODDS RATIO; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SMOKING; TENNESSEE; TOBACCO SMOKE POLLUTION; TREATMENT FAILURE;

EID: 79955837457     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2011.03.100180     Document Type: Review

References (111)

1. National Institutes of Health. Expert Panel Report 3. Guidelines for the diagnosis and management of asthma. NIH Publication No. 07-4051Bethesda, MD: National Institutes of Health; 2007.
2. Peters JM, Avol E, Navidi W, et al. A study of twelve Southern California communities with differing levels and types of air pollution: I. Prevalence of respiratory morbidity. Am J Respir Crit Care Med 1999;159:760-7. (Pubitemid 29137771)
3. Van der Vaart H, Postma DS, et al. Acute effects of cigarette smoking on inflammation in healthy intermittent smokers. Respir Res 2005;6:22.
4. Boulet L-P, Lemiere C, Archambault F, et al. Smoking and asthma: clinical and radiologic features, lung function, and airwary inflammation. Chest 2006;129:661-8.
5. Floreani A and Rennard S. The role of cigarette smoke in the pathogenesis of asthma and as a trigger for acute symptoms. Curr Opin Pulm Med 1999;5:38-46.
6. Yanbaeva DG, Dentener MA, Creutzberg EC, et al. Systemic effects of smoking. Chest 2007;131: 1557-66. (Pubitemid 46762366)
7. Chalmers G, MacLeod KJ, Thomson L, et al. Smoking and airway inflammation in patients with mild asthma. Chest 2001;120:1917-22. (Pubitemid 34053454)
8. Kent L, Smyth L, Clayton C, et al. Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophages. Cytokine 2008;42:205-16.
9. Birrell MA, Wong S, Catley MC, et al. Impact of tobacco smoke on key signaling pathways in the innate immune response in lung macrophages. J Cell Physiol 2008;214:27-37. (Pubitemid 350220056)
10. Kostikas K, Gaga M, Papatheodorou G, et al. Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 2005;127:1553-9. (Pubitemid 46218778)
11. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation, and autoimmunity. J Autoimmun 2010;34:258-65.
12. McKay A, Komai-Koma M, MacLeod K, et al. Interleukin-18 levels in induced sputum and reduced in asthmatic and normal smokers. Clin Exp Allergy 2004;34:904-10.
13. Kanazawa H, Tochino Y, Kyoh S, et al. Increased levels of angiopoietin-2 in induced sputum from smoking asthmatic patients. Clin Exp Allergy 2009; 39:1330-7.
14. Krisiukeniene A, Babusyte A, Stravinskaite K, et al. Smoking affects eotaxin levels in asthma patients. J Asthma 2009;46:470-6.
15. Piipari R, Jaakkola JJK, Jaakkola N, et al. Smoking and asthma in adults. Eur Respir J 2004;24:734-9. (Pubitemid 39504424)
16. Gilliland FD, Islan T, Berthane K, et al. Regular smoking and asthma incidence in adolescents. Am J Respir Crit Care Med 2006;174:1094-100. (Pubitemid 44772079)
17. Schatz M, Zeiger RS, Vollmer WM, et al. Determinants of future long-term asthma control. J Allergy Clin Immunol 2006;118:1048-53. (Pubitemid 44666992)
18. McCoy K, Shade DM, Irvin CG, et al. Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol 2006;118:1226-33. (Pubitemid 44854130)
19. Strine TW, Balluz LS, Ford ES. The associations between smoking, physical inactivity, obesity, and asthma severity in the general US population. J Asthma 2007;44:651-8. (Pubitemid 47621476)
20. Chaudhuri R, McSharry C, McCoard A, et al. Role of symptoms and lung function in determining asthma control in smokers with asthma. Allergy 2008;63:132-5. (Pubitemid 350198240)
21. Chapman KR, Boulet LP, Rea RM, et al. Suboptimal asthma control: prevalence, detection, and consequences in general practice. Cur Respir J 2008; 31:320-5.
22. Laforest L, Van Ganse E, Devouassoux G, et al. Influence of patients' characteristics and disease management on asthma control. J Allergy Clin Immunol 2006;117:1404-10. (Pubitemid 43795749)
23. Leuppi, JD, Steurer-Stey C, Peter M, et al. Asthma control in Switzerland: a general practitioner based study. Curr Med Res Opin 2006;22(11):2159-66. (Pubitemid 44789980)
24. US Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention, Office of Smoking and Health; 2006.
25. Reardon JZ. Environmental tobacco smoke: respiratory and other health effects. Clin Chest Med 2007;28:559-73. (Pubitemid 47287709)
26. Chan-Yeung M, Dimich-Ward H. Respiratory health effects of exposure to environmental tobacco smoke. Respirology 2003;8:131-9. (Pubitemid 36749693)
27. Kumar R, Curtis LM, Khiani S, et al. A community-based study of tobacco smoke exposure among inner-city children with asthma in Chicago. J Allergy Clin Immunol 2008;122:754-9.
28. Benowitz NL. Continine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 1996;18:188-204. (Pubitemid 27082089)
29. Leong JW, Dore ND, Shelley K, et al. The elimination half-life of urinary continine in children of tobacco-smoking mothers. Pulm Pharmacol Ther 1998;11:287-90. (Pubitemid 29078053)
30. Knight JM, Eliopoulos C, Klein J, et al. Passive smoking in children: racial differences in systemic exposure to continine by hair and urine analysis. Chest 1996;109:446-50. (Pubitemid 26058603)
31. Knight JM, Eliopoulos C, Klein J, et al. Pharmacokinetic predisposition to nicotine from environmental tobacco smoke: a risk factor for pediatric asthma. J Asthma 1998;35:113-7. (Pubitemid 28135003)
32. Halterman JS, Borelli B, Tremblay P, et al. Screening for environmental tobacco smoke exposure among inner-city children with asthma. Pediatrics 2008;122:1277-83.
33. Groner JA, Hoshaw-Woodard S, Koren G, et al. Screening for children's exposure to environmental tobacco smoke in pediatric primary care setting. Arch Pediatr Adolesc Med 2005;159:450-5. (Pubitemid 40632134)
34. Center for Disease Control. Tobacco use: targeting the nation's leading killer at a glance 2011. Available at: http://www.cdc.gov/chronicdisease/ resources/publications/aag/osh.htm. Accessed November 2010.
35. Glantz SA and Parmley WW. Passive smoking and heart disease: epidemiology, physiology, and biochemistry. Circulation 1991;83:1-12.
36. Taylor AE, Johnson DC, and Kazemi H. Environmental Tobacco Smoke and Cardiovascular Disease: a position paper from the council on cardiopulmonary and critical care. American Heart Association. Circulation 1992;86:699-702.
37. Glantz SA, Parmley WW. Passive smoking and heart disease: mechanism and risk. JAMA 1995;273: 1047-53.
38. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Guidelines: global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2009. Available at: http://www.goldcopd. com/Guidelineitem.asp?l1=2&l2=1&intId=2003. Accessed November 2010.
39. Maier WC, Arrighi HM, Morray B, et al. Indoor risk factors for asthma and wheezing among Seattle school children. Environ Health Perspect 1997; 105:208-14. (Pubitemid 27196410)
40. Lam TH, Chung SF, Betson CL, et al. Respiratory symptoms due to active and passive smoking in junior secondary school students in Hong Kong. Int J Epidemiol 1998;27:41-8. (Pubitemid 28140501)
41. Butland BK, Strachan DP, Anderson HR. The home environment and asthma symptoms in childhood: two population based case-control studies 13 years apart. Thorax 1997;52:618-24. (Pubitemid 27342210)
42. Morkjaroenpong V, Rand CS, Butz AM, et al. Environmental tobacco smoke exposure and nocturnal symptoms among inner-city children with asthma. J Allergy Clin Immunol 2002;110:147-53. (Pubitemid 36132741)
43. Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. N Engl J Med 1995;332:133-8.
44. Strachan DP, Cook DG. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax 1998;53:204-12. (Pubitemid 28172374)
45. Kurukulaaratchy RJ, Waterhouse L, Matthews SM, et al. Are influences during pregnancy associated with wheezing phenotypes during the first decade of life? Acta Paediatrica 2005;94:553-8.
46. Lannero E, Wickman M, Pershagen G, et al. Maternal smoking during pregnancy increases the risk of wheezing during the first years of life (BAMSE). Respir Res 2006;7:3.
47. Gilliland FD, Berhane K, McConnell R, et al. Maternal smoking during pregnancy, environmental tobacco smoke exposure and childhood lung function. Thorax 2000;55:271-6. (Pubitemid 30248795)
48. Pattenden S, Antova T, Neuberger M, et al. Parental smoking and children's respiratory health: independent effects of prenatal and postnatal exposure. Tob Control 2006;15:294-301. (Pubitemid 44187515)
49. Gilliland FD, Berhane K, Li YF, et al. Effects of early onset asthma and in utero exposure to maternal smoking on childhood lung function. Am J Respir Crit Care Med 2003;167:917-24. (Pubitemid 36801782)
50. Cunningham J, Dockery DW and Speizer FE. Maternal smoking during pregnancy as a predictor of lung function in children. Am J Epidemiol 1994; 139:1139-52. (Pubitemid 24184408)
51. Tager IB, Ngo L, Hanrahan JP. Maternal smoking during pregnancy. Effects on lung function during the first 18 months of life. Am J Respir Crit Care Med 1995;152:977-83.
52. Stick SM, Burton PR, Gurrin L, et al. Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants. Lancet 1996;348:1060-4. (Pubitemid 26343600)
53. Carlsen KCL, Jaakkola JJK, Nafstad P, et al. In utero exposure to cigarette smoking influences lung function at birth. Eur Respir J 1997;10: 1774-9.
54. Hoo AF, Henschen M, Dezateux C, et al. Respiratory function among preterm infants whose mothers smoked during pregnancy. Am J Respir Crit Care Med 1998;158:700-5. (Pubitemid 28449429)
55. Dezateux C, Stocks J, Dundas I, et al. Impaired airway function and wheezing in infancy: the influence of maternal smoking and a genetic predisposition to asthma. Am J Respir Crit Care Med 1999; 159:403-10. (Pubitemid 29084858)
56. Gilliland FD, Li YF, Peters JM. Effects of maternal smoking during pregnancy and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med 2001;163:429-36. (Pubitemid 32158524)
57. Li YF, Langholz B, Salam MT, et al. Maternal and grandmaternal smoking patterns are associated with early childhood asthma. Chest 2005;127:1232-41. (Pubitemid 46224286)
58. Yamasaki A, Hanaki K, Tomita K, et al. Environmental tobacco smoke and its effect on the symptoms and medication in children with asthma. Int J Environ Health Res 2009;19:97-108.
59. Goodwin RD. Environmental tobacco smoke and the epidemic of asthma in children: the role of cigarette use. Ann Allergy Asthma Immunol 2007; 98:447-54. (Pubitemid 46752638)
60. De Boeck K, Moens M, Van Der Aa N, et al. 'Difficult asthma': can symptoms be controlled in a structured environment? Pediatr Pulmonol 2009; 44:743-8.
61. Lawson JA, Dosman JA, Rennie DC, et al. Relationship between indoor environment and asthma and wheeze severity among rural children and adolescents. J Agromedicine 2009;14:277-85.
62. McGhan SL, MacDonald C, James DE, et al. Factors associated with poor asthma control in children aged five to 13 years. Can Respir J 2006;13:23-9.
63. Rayens MK, Burkhart PV, Zhang M, et al. Reduction in asthma-related emergency department visits after implementation of a smoke-free law. J Allergy Clin Immunol 2008;122:537-41.
64. Mahabee-Gittens M. Smoking in parents of children with asthma and bronchiolitis in a pediatric emergency department. Ped Emerg Care 2002;18:4-7. (Pubitemid 34174334)
65. Vargas PA, Brenner B, Clark S, et al. Exposure to environmental tobacco smoke among children presenting to the emergency department with acute asthma: a multicenter study. Pediatr Pulmon 2007; 42:646-55. (Pubitemid 47021058)
66. Gerald LB, Gerald JK, Gibson L, et al. Changes in environmental tobacco exposure and asthma morbidity among urban school children. Chest 2009; 135:911-6.
67. Cook DG, Whincup PH, Jarvis MJ, et al. Passive exposure to tobacco smoke in children aged 5-7 years: individual, family, and community factors. BMJ 1994;308:384-9.
68. Oddoze C, Dubus JC, Badier M, et al. Urinary continine and exposure to parental smoking in a population of children with asthma. Clin Chem 1999;45:505-9. (Pubitemid 29165960)
69. Irvine L, Crombie IK, Clark RA, et al. What determines levels of passive smoking in children with asthma? Thorax 1997;52:766-9.
70. Wilson SR, Yamada EG, Sudhakar R, et al. A controlled trial of an environmental tobacco reduction intervention in low-income children with asthma. Chest 2001;120:1709-22. (Pubitemid 33078494)
71. Gilliland FD, Behane K, Islam T, et al. Environmental tobacco smoke and absenteeism related to respiratory illness in school-children. Am J Epidemiol 2003;157:861-9. (Pubitemid 36555044)
72. Li YF, Gilliland FD, Berhane K, et al. Effects of in utero and environmental tobacco smoke exposure on lung function in boys and girls with and without asthma. Am J Respir Crit Care Med 2000;162: 2097-104. (Pubitemid 32051670)
73. Arshad SH, Kurukulaaratchy RJ, Fenn M, et al. Early life risk factors for current wheeze, asthma, and bronchial hyperresponsiveness at 10 years of age. Chest 2005;127:502-8. (Pubitemid 40229309)
74. Mannino DM, Homa DM, Redd SC. Involuntary smoking and asthma severity in children: Data from the third national health and nutrition examination survey. Chest 2002;122:409-15. (Pubitemid 35002114)
75. Schwartz J, Timonen KL, Pekkanen J. Respiratory effects of environmental tobacco smoke in a panel study of asthmatic and symptomatic children. Am J Respir Crit Care Med 2000;161:802-6. (Pubitemid 30171734)
76. Leson S, Gershwin ME. Risk factors for asthmatic patients requiring intubation. I. Observations in children. J Asthma 1995;32:285-94.
77. LeSon S, Gershwin ME. Risk factors for asthmatic patients requiring intubation. III. Observations in young adults. J Asthma 1996;33:27-35. (Pubitemid 26058824)
78. Ebbert JO, Croghan IT, Schroeder DR, et al. Association between respiratory tract diseases and secondhand smoke exposure among never smoking flight attendants: a cross-sectional survey. Environ Health 2007;6:28.
79. Jindal SK, Gupta D, Singh A. Indices of morbidity and control of asthma in adult patients exposed to environmental tobacco smoke. Chest 1994;106: 746-9. (Pubitemid 24278877)
80. Pedersen B, Dahl R, Karlstrom R, et al. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. Am J Respir Crit Care Med 1996;153:1519-29. (Pubitemid 26141335)
81. Chalmers GW, Macleod KJ, Little SA, et al. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002;57:226-30. (Pubitemid 34214408)
82. Chaudhuri R, Livingston E, McMahon AD, et al. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003;168:1308-11. (Pubitemid 37487324)
83. Jang As, Lee JH, Park SW, et al. Factors influencing the responsiveness to inhaled glucocorticoids of patients with moderate-to-severe asthma. Chest 2005;128:1140-5. (Pubitemid 41324388)
84. Tomlinson JEM, McMahon AD, Chaudhuri R, et al. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2005;60:282-7. (Pubitemid 40522363)
85. Lazarus SC, Chinchilli VM, Rollings NJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007;175:783-90. (Pubitemid 46631789)
86. Pedersen SE, Bateman ED, Bousquet J, et al. Determinants of response to fluticasone propionate and salmeterol/fluticasone propioinate combination in the Gaining Optimal Asthma Control study. J Allergy Clin Immunol 2007;120:1036-42. (Pubitemid 350029898)
87. Dijkstra A, Vonk JM, Jongepier H, et al. Lung function decline in asthma: association with inhaled corticosteroids, smoking, and sex. Thorax 2006;61:105-10. (Pubitemid 43235425)
88. Lange P, Scharling H, Ulrik CS, et al. Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax 2006;61:100-4. (Pubitemid 43235424)
89. O'Byrne PM, Lamm CJ, Busse WW, et al. The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma. Chest 2009;136:1514-20.
90. Halterman JS, Szilagyi PG, Yoos JL, et al. Benefits of a school-based asthma treatment program in the absence of secondhand smoke exposure. Arch Pediatr Adolesc med 2004;158:460-7. (Pubitemid 38623583)
91. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J 2004;24:822-33. (Pubitemid 39504438)
92. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-1200.
93. Barnes P. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. Eur Respir J 2002;19:182-91. (Pubitemid 34105586)
94. Galigniana MD, Piwien-Pilipuk G, Assreuy J. Inhibition of glucocorticoid receptor binding by nitric oxide. Mol Pharmacol 1999;55:317-23. (Pubitemid 29076029)
95. Wang H, Yu M, Ocham M, et al. Nicotinic acetylcholine receptor 7 subunit is an essential regulator of inflammation. Nature 2003;421:348-88.
96. Rahman I, MacNee W. Role of transcription factors in inflammatory lung disease. Thorax 1998;53: 601-12. (Pubitemid 28335523)
97. Ito K, Lim S, Caramori G, et al. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001;15: 1110-2.
98. Irusen E, Matthews J, Takahashi A, et al. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J Allergy Clin Immunol 2002;109:649-57. (Pubitemid 34327193)
99. Kennedy S, Elwood R, Wiggs B, et al. Increased airway mucosal permeability of smokers: relationship to airway reactivity. Am Rev Respir Dis 1984; 129:143-8. (Pubitemid 14176518)
100. 99mTc-DTPA in asthma. Am Rev Respir Dis 1988;139:1139-43.
101. Laustiola K, Lassilia R, Kaprio J, et al. Decreased beta-adrenergic receptor density and catecholamine response in male cigarette smokers: a study of monozygotic twin pairs discordant for smoking. Circulation 1988;78:1234-40.
102. Byron K, Varigos G, Wootton A. IL-4 production is increased in cigarette smokers. Clin Exp Immunol 1994;95:333-6. (Pubitemid 24207149)
103. Keatings V, Collins P, Scott D, et al. Differences in interleukin-8 and tumour necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease disease and asthma. Am J Respir Crit Care Med 1996;153:530-4.
104. Churg A, Dai J, Changshi X, et al. Tumour necrosis factor-α is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med 2002;166:849-54.
105. Hawrylowicz C, Richards D, Loke T-K, et al. A defect in corticosteroid-induced IL-10 production in T lymphocytes from corticosteroid-resistant patients. J Allergy Clin Immunol 2002;109:369-70. (Pubitemid 34158308)
106. Oakley RH, Jewell CM, Yudt MR, et al. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. J Biol Chem 1999;274:27857-66.
107. Pujols L, Mullol J, Perez M, et al. Expression of the human glucocorticoid receptor alpha and beta isoforms in human respiratory epithelial cells and their regulation by dexamethasone. Am J Respir Cell Mol Biol 2001;24:49-57. (Pubitemid 32099724)
108. Levy DT, Romano E, Mumford EA. Recent trends in home and work smoking bans. Tob Control 2004;13(3):258-63. (Pubitemid 39451994)
109. Farber HJ, Knowles SB, Brown NL, et al. Secondhand tobacco smoke in children with asthma. Chest 2008;133:1367-74.
110. Winickoff JP, Tanski SE, McMillen RC, et al. A National survey of the acceptability of quitlines to help parents quit smoking. Pediatrics 2006;117: 695-700.
111. Hymowitz N, Schwab J, Haddock CK, et al. The pediatric resident training on tobacco project: baseline findings from the parent/guardian tobacco survey. Prev Med 2005;41:334-41. (Pubitemid 40755098)